Please login to the form below

Not currently logged in
Email:
Password:

canakinumab

This page shows the latest canakinumab news and features for those working in and with pharma, biotech and healthcare.

Novartis’ canakinumab misses the mark in previously treated NSCLC

Novartis’ canakinumab misses the mark in previously treated NSCLC

Novartis is continuing two additional studies of canakinumab in NSCLC, in the first-line and adjuvant settings. ... Previously, Novartis had attempted to expand the use of canakinumab as a potential cardiovascular treatment.

Latest news

More from news
Approximately 4 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...